208 related articles for article (PubMed ID: 35815689)
21. Ocular amphotericin B delivery by chitosan-modified nanostructured lipid carriers for fungal keratitis-targeted therapy.
Fu T; Yi J; Lv S; Zhang B
J Liposome Res; 2017 Sep; 27(3):228-233. PubMed ID: 27601177
[TBL] [Abstract][Full Text] [Related]
22. Voriconazole Ternary Micellar Systems for the Treatment of Ocular Mycosis: Statistical Optimization and In Vivo Evaluation.
Fahmy AM; Hassan M; El-Setouhy DA; Tayel SA; Al-Mahallawi AM
J Pharm Sci; 2021 May; 110(5):2130-2138. PubMed ID: 33346033
[TBL] [Abstract][Full Text] [Related]
23. Enhancing and sustaining the topical ocular delivery of fluconazole using chitosan solution and poloxamer/chitosan in situ forming gel.
Gratieri T; Gelfuso GM; de Freitas O; Rocha EM; Lopez RF
Eur J Pharm Biopharm; 2011 Oct; 79(2):320-7. PubMed ID: 21641994
[TBL] [Abstract][Full Text] [Related]
24. Nanomicelles empower natamycin in treating fungal keratitis: An in vitro, ex vivo and in vivo study.
Sathe P; Kailasam V; Nagarjuna V; Sharma H; Velpandian T; Garg P; Nirmal J
Int J Pharm; 2024 May; 656():124118. PubMed ID: 38615806
[TBL] [Abstract][Full Text] [Related]
25. Enhancement of the topical tolnaftate delivery for the treatment of tinea pedis via provesicular gel systems.
AbouSamra MM; Salama AH
J Liposome Res; 2017 Dec; 27(4):324-334. PubMed ID: 27666873
[TBL] [Abstract][Full Text] [Related]
26. Formulation and in vivo assessment of terconazole-loaded polymeric mixed micelles enriched with Cremophor EL as dual functioning mediator for augmenting physical stability and skin delivery.
Abd-Elsalam WH; El-Zahaby SA; Al-Mahallawi AM
Drug Deliv; 2018 Nov; 25(1):484-492. PubMed ID: 29411650
[TBL] [Abstract][Full Text] [Related]
27. Sertaconazole-Nitrate-Loaded Leciplex for Treating Keratomycosis: Optimization Using D-Optimal Design and In Vitro, Ex Vivo, and In Vivo Studies.
Abdellatif MM; Josef M; El-Nabarawi MA; Teaima M
Pharmaceutics; 2022 Oct; 14(10):. PubMed ID: 36297650
[TBL] [Abstract][Full Text] [Related]
28. Pronounced capping effect of olaminosomes as nanostructured platforms in ocular candidiasis management.
Ahmed S; Amin MM; El-Korany SM; Sayed S
Drug Deliv; 2022 Dec; 29(1):2945-2958. PubMed ID: 36073061
[TBL] [Abstract][Full Text] [Related]
29. In vitro and in vivo evaluation of cubosomal nanoparticles as an ocular delivery system for fluconazole in treatment of keratomycosis.
Nasr M; Teiama M; Ismail A; Ebada A; Saber S
Drug Deliv Transl Res; 2020 Dec; 10(6):1841-1852. PubMed ID: 32779112
[TBL] [Abstract][Full Text] [Related]
30. Ocular ketoconazole-loaded proniosomal gels: formulation, ex vivo corneal permeation and in vivo studies.
Abdelbary GA; Amin MM; Zakaria MY
Drug Deliv; 2017 Nov; 24(1):309-319. PubMed ID: 28165809
[TBL] [Abstract][Full Text] [Related]
31. Development of a Novel Bilosomal System for Improved Oral Bioavailability of Sertraline Hydrochloride: Formulation Design, In Vitro Characterization, and Ex Vivo and In Vivo Studies.
Ismail A; Teiama M; Magdy B; Sakran W
AAPS PharmSciTech; 2022 Jul; 23(6):188. PubMed ID: 35799076
[TBL] [Abstract][Full Text] [Related]
32. Intranasal brain-targeted clonazepam polymeric micelles for immediate control of status epilepticus: in vitro optimization, ex vivo determination of cytotoxicity, in vivo biodistribution and pharmacodynamics studies.
Nour SA; Abdelmalak NS; Naguib MJ; Rashed HM; Ibrahim AB
Drug Deliv; 2016 Nov; 23(9):3681-3695. PubMed ID: 27648847
[TBL] [Abstract][Full Text] [Related]
33. Cubogel as potential platform for glaucoma management.
Sayed S; Abdel-Moteleb M; Amin MM; Khowessah OM
Drug Deliv; 2021 Dec; 28(1):293-305. PubMed ID: 33509004
[TBL] [Abstract][Full Text] [Related]
34. Hyalugel-integrated liposomes as a novel ocular nanosized delivery system of fluconazole with promising prolonged effect.
Moustafa MA; Elnaggar YSR; El-Refaie WM; Abdallah OY
Int J Pharm; 2017 Dec; 534(1-2):14-24. PubMed ID: 28987453
[TBL] [Abstract][Full Text] [Related]
35. Recent advances in nanotechnology for the treatment of fungal keratitis.
Zhang F; Zhang J; Zhang W
Eur J Ophthalmol; 2024 Jan; 34(1):18-29. PubMed ID: 37198915
[TBL] [Abstract][Full Text] [Related]
36. Ocular Inserts of Voriconazole-Loaded Proniosomal Gels: Formulation, Evaluation and Microbiological Studies.
El-Emam GA; Girgis GNS; El-Sokkary MMA; El-Azeem Soliman OA; Abd El Gawad AEGH
Int J Nanomedicine; 2020; 15():7825-7840. PubMed ID: 33116503
[TBL] [Abstract][Full Text] [Related]
37. Biocompatible phospholipid-based mixed micelles for posaconazole ocular delivery: Development, characterization, and in - vitro antifungal activity.
Osouli M; Abdollahizad E; Alavi S; Mahboubi A; Abbasian Z; Haeri A; Dadashzadeh S
J Biomater Appl; 2023 Jan; 37(6):969-978. PubMed ID: 36424544
[TBL] [Abstract][Full Text] [Related]
38. Statistical optimization of hyaluronic acid enriched ultradeformable elastosomes for ocular delivery of voriconazole via Box-Behnken design:
Fahmy AM; Hassan M; El-Setouhy DA; Tayel SA; Al-Mahallawi AM
Drug Deliv; 2021 Dec; 28(1):77-86. PubMed ID: 33342315
[TBL] [Abstract][Full Text] [Related]
39. Development and evaluation of surfactant-based elastic vesicular system for transdermal delivery of Cilostazole:
Nemr AA; El-Mahrouk GM; Badie HA
J Liposome Res; 2022 Jun; 32(2):159-171. PubMed ID: 33970754
[TBL] [Abstract][Full Text] [Related]
40. Enhancement of lomefloxacin Hcl ocular efficacy via niosomal encapsulation: in vitro characterization and in vivo evaluation.
Khalil RM; Abdelbary GA; Basha M; Awad GEA; El-Hashemy HA
J Liposome Res; 2017 Dec; 27(4):312-323. PubMed ID: 27241274
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
